advertiser banner advertiser banner advertiser banner
Digital Issues

Home >  News >  August, 2014

Drug Maker Introduces 10 mL Propofol

Smaller portions reduce waste and support safety.

Published: August 12, 2014

During the recent propofol shortage, many anesthesia providers complained that the IV sedative-hypnotic's large, single-use-only vials led to excessive waste after short cases that required only small amounts of the drug. With the introduction of propofol packaged in smaller vials, however, a German pharmaceutical manufacturer has introduced an effective solution.

Fresenius Kabi is offering its Diprivan (propofol) injectable emulsion, USP, in 10mL vials, the first drug maker to do so. The company received FDA approval for the portioning, which joins its 20-, 50- and 100mL sizes, in June.

"The Diprivan 10mL presentation is designed with consideration for common dosing practices to support single patient use and reduce waste," says John Ducker, president and CEO of the company's U.S. division in Lake Zurich, Ill., in a statement. "This is particularly important for outpatient surgery centers where lower doses are commonly administered."

The size of propofol vials became a point of contention in the lawsuits that followed the 2008 Nevada hepatitis C outbreak. Manufacturer Teva Parenteral Medicines and distributors Baxter Healthcare and McKesson Medical Surgical were ordered to pay a group of infected patients $183.6 million in October 2011 after a judge agreed that 50mL and 100mL vials marketed without single-use-only restrictions encouraged an endoscopy center's staff to reuse the vials, and consequently cross-contaminate patients.

David Bernard


Also in the News...

CMS Announces Outpatient Rates for 2016
Patient Says She Was Bullied into Signing Consent Form
Connecticut Provider Tax Could Force Centers to Close Across State
Insufficient Evidence to Link Nail Polish, Rings to SSIs
Colonoscopy Patient's Cell Phone Records Doctor's Insults
Florida Skin-Cancer Doc Agrees to Pay Feds $4 Million
Can Antibiotics Successfully Treat Appendicitis?

 
Have an account? Please log in:
Email Address:
  Remember my login on this computer

DID YOU SEE THIS?

advertiser banner

Other Articles That May Interest You

Doc with Positive Drug Test Gets Green Light to Return

Agreement with state's Department of Health includes ongoing monitoring.

Deadly Superbug-Related Scopes Sold Without FDA Approval

FDA: Olympus never obtained permission to sell the duodenoscope connected to 2 superbug deaths.

Our 2014 Salary Survey Results Are In

See how your paycheck compares to your colleagues in Outpatient Surgery Magazine's 2014 Salary Survey.